Hygieia Innovation develops novel stem cell therapeutics to address major unmet medical needs. The company is focused on developing tailor-made stem cell based therapies which are more accurate, efficacious and safe for various degenerative diseases. The company is able to readily up scale the production of cell lines for clinical and commercial use. This gives Hygieia Innovation a significant competitive advantage in terms of time and cost in moving potential stem cell therapy through a clinical development programme. Its allogeneic stem cell model – an “off-the-shelf’ stem cell product, has tremendous potential with batch to batch consistency and low manufacturing cost to provide affordability, safety and efficacy.